Greenwich Biosciences, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
US General Counsel and Compliance Officer
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
US General Counsel and Compliance Officer
Contact
AR
Angelique Rowley
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 49
Toggle details
Assembly Bill 49
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
Other
Notification Date2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 183
Toggle details
Assembly Bill 183
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
None
Notification Date10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 10
Toggle details
Senate Bill 10
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2017 Wisconsin Act 4
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2017 Wisconsin Act 4
Other
Notification Date2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 119
Toggle details
Senate Bill 119
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2017 Wisconsin Act 100
10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2017 Wisconsin Act 100
None
Notification Date10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Development, drafting or introduction of a proposal relating to
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $27,000.00 |
2017 July - December $28,376.43 |
2018 January - June $27,000.00 |
2018 July - December $28,002.00 |
Total $110,378.43 |
| Total Hours Communicating | 2017 January - June 7.50 |
2017 July - December 7.50 |
2018 January - June 2.25 |
2018 July - December 1.75 |
Total 19.00 |
| Total Hours Other | 2017 January - June 25.75 |
2017 July - December 31.00 |
2018 January - June 15.50 |
2018 July - December 46.25 |
Total 118.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 30% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 7% |
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 50% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 12% |
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 15% |
2018 January - June |
2018 July - December |
Total 4% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 20% |
2017 July - December 70% |
2018 January - June 90% |
2018 July - December 60% |
Total 57% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication